Payne Joseph E 4
4 · Vallon Pharmaceuticals, Inc. · Filed May 27, 2021
Insider Transaction Report
Form 4
Payne Joseph E
Director10% Owner
Transactions
- Purchase
Common Stock
2021-05-25$3.85/sh+10,700$41,195→ 10,700 total - Purchase
Common Stock
2021-05-26$4.50/sh+6,800$30,600→ 17,500 total
Holdings
- 843,750(indirect: By Arcturus Therapeutics, Inc.)
Common Stock
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.